Pay in 4 interest-free payments of $6.59 Learn more
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14
Theoretically this interaction is possible with other proton pump inhibitors (PPIs), although specific clinical data are lacking
Clinical trials showed that AOD-9604 has no effect on IGF-1 levels and does not interfere with glucose metabolism, making it compatible with various metabolic protocols
In other words, AOD-9604 is a fat-burning molecule
Available in 3 stacks save up to 170,00 Metabolic Cut - Startsave 52,00 View the stack Metabolic Cut - Advancedsave 148,00 View the stack Energy - Advancedsave 170,00 View the stack 5-Amino-1MQ - Fat Metabolism & NAD+ Pathway Modulator Promotes metabolic rate and energy efficiency Supports the reduction of fat accumulation, particularly in white adipose tissue Acts to increase essential intracellular NAD+ levels Observed to reduce fat cell size and suppress new fat storage Helps maintain healthy blood sugar control and insulin sensitivity Enhances the function and efficiency of cellular powerhouses Studied for its role in supporting grip strength and lean mass preservation Research explores its activation of NAD+-dependent longevity pathways Description 5-Amino-1MQ is a small molecule NNMT inhibitor studied for its ability to modulate cellular metabolism through methylation and NAD+ salvage pathways
However, there is no strong scientific evidence to suggest that B12 injections directly lead to increased fat burn or significantly impact metabolism for people who are not deficient
